CEDIA for screening drugs of abuse in urine and the effect of adulterants

AHB Wu, E Forte, G Casella… - Journal of …, 1995 - asmedigitalcollection.asme.org
The performance of the Microgenics CEDIA® DAU assays for screening amphetamines,
barbiturates, benzodiazepines, cocaine, opiates, phencylidine (PC), and …

Evaluation of the Abuscreen® for Methadone

T Manning, JH Bidanset… - Journal of forensic …, 1976 - asmedigitalcollection.asme.org
Evaluation of the Abuscreen for Methadone Page 1 Thomas Manning, 1 MS, JH Bidanset, 1 Ph,
D., Stephen Cohen, ~ BS, and Leslie Lukash, ' MD Evaluation of the Abuscreen | for Methadone …

A Novel Procedure for the Analysis of Drugs in Whole Blood by Homogeneous Enzyme Immunoassay (EMIT®)

LJ Lewellen, HH McCurdy - Journal of analytical toxicology, 1988 - academic.oup.com
This paper describes a procedure for the analysis of whole blood by six commonly used
EMIT dau, assays: barbiturates, benzodiazepines, cocaine metabolite, opiates …

Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups

CN Lin, GJ Nelson, GA McMillin - Journal of analytical …, 2013 - academic.oup.com
Urine drug testing is an important tool that is commonly used to assess patient compliance
with prescription regimens. Point-of-collection immunoassay devices allow for timely …

Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry

RL Fitzgerald, DA Rexin, DA Herold - Clinical chemistry, 1994 - academic.oup.com
We tested 231 urine samples by six immunoassay methods--EMIT dau, EMIT II, Roche
Abuscreen Online, Abbott TDx, Diagnostic Products Corp.(DPC) double-antibody …

Evaluation of the integrated EZ split key® cup II for rapid detection of twelve drug classes in urine

DN Greene, CM Lehman… - Journal of analytical …, 2011 - academic.oup.com
The availability of point-of-care (POC) medical devices for drug testing has surged.
Reduction in turnaround time, and hence, rapid results are attractive, particularly to acute …

On-site testing of illicit drugs: the use of the drug-testing device “Toxiquick®”

T Biermann, B Schwarze, B Zedler, P Betz - Forensic science international, 2004 - Elsevier
Since 1998, driving under the influence of drugs such as amphetamine, MDMA, MDE,
cannabis, cocaine, heroine and morphine is sanctioned due to Section 24a of the Road …

Interpretation and utility of drug of abuse immunoassays: lessons from laboratory drug testing surveys

SEF Melanson, L Baskin, B Magnani… - … of pathology & …, 2010 - meridian.allenpress.com
Context.—To assist with patient diagnosis and management, physicians from pain services,
drug treatment programs, and the emergency department frequently request that urine be …

Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents

G Pelletti, M Garagnani, F Rossi, R Roffi… - Forensic science …, 2019 - Elsevier
Introduction Immunoassay (IA) tests should be able to detect low concentrations of illegal
drugs when used for the screening of drugs in drivers. False negatives should be avoided …

Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT)

JM Yang, KB Lewandrowski - Clinica chimica acta, 2001 - Elsevier
We evaluated a new point-of-care (POC) device for urine drugs of abuse (DOA) screening
including appropriate clinical interpretation and potential benefits in a large academic …